The University of Melbourne Collaborative Centre for Genomic Cancer Medicine

Site

UMCCGCM

Accreditation No.

3196

Site No.

3189

Date of Accreditation

10 Jul 1991

Address

The University of Melbourne Collaborative Centre for Genomic Cancer Medicine, Level 10, 305 Grattan Street
Melbourne, VIC 3000
Australia

genomic-cancer-medicine.unimelb.edu.au

Contact

Availability

Services conditionally available to external clients

Supervision

Not Applicable

The University of Melbourne Collaborative Centre for Genomic Cancer Medicine address map

Scope of Accreditation

Print scopes
UMCCGCM

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Molecular genetics - DNA extraction Blood; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue Viable DNA; Viable DNA for sequencing
Molecular genetics - DNA sequencing Purified PCR product Sequenced DNA utilising massively parallel sequencing technologies
Molecular genetics - Detection and characterisation of cell free RNA (cfRNA)/cell free DNA (cfDNA)/cell free TNA (cfTNA)/circulating tumour DNA (ctDNA)  in cancer screening and/or cancer genetic testing Plasma Nucleic acid analysis for specific variants
Molecular genetics/Cytogenetics - Bioinformatic analysis DNA sequences Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.